Eagle Health Investments LP Reduces Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Eagle Health Investments LP trimmed its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 40.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 4,390 shares of the medical equipment provider’s stock after selling 3,000 shares during the quarter. Intuitive Surgical comprises 0.6% of Eagle Health Investments LP’s holdings, making the stock its 15th largest position. Eagle Health Investments LP’s holdings in Intuitive Surgical were worth $2,291,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Atala Financial Inc acquired a new stake in Intuitive Surgical during the 4th quarter valued at approximately $25,000. Berbice Capital Management LLC acquired a new position in Intuitive Surgical during the fourth quarter valued at $26,000. BankPlus Trust Department purchased a new stake in Intuitive Surgical in the fourth quarter valued at $28,000. Kohmann Bosshard Financial Services LLC acquired a new stake in Intuitive Surgical during the 4th quarter worth about $31,000. Finally, Decker Retirement Planning Inc. purchased a new position in shares of Intuitive Surgical during the 4th quarter valued at about $36,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $509.03 on Thursday. The stock’s 50 day simple moving average is $559.82 and its 200-day simple moving average is $532.42. The stock has a market cap of $181.31 billion, a P/E ratio of 79.41, a P/E/G ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

Analyst Ratings Changes

Several research firms recently commented on ISRG. Robert W. Baird dropped their target price on Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating on the stock in a report on Tuesday, March 18th. Evercore ISI lifted their target price on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. UBS Group increased their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a report on Monday, January 27th. Erste Group Bank downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 17th. Finally, Truist Financial cut their price target on Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating for the company in a research note on Monday, March 17th. One analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $611.86.

Insiders Place Their Bets

In related news, VP Fredrik Widman sold 810 shares of the company’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $573.78, for a total value of $464,761.80. Following the completion of the sale, the vice president now owns 473 shares of the company’s stock, valued at approximately $271,397.94. This represents a 63.13 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, SVP Mark Brosius sold 492 shares of Intuitive Surgical stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $282,299.76. Following the transaction, the senior vice president now directly owns 4,056 shares in the company, valued at $2,327,251.68. This trade represents a 10.82 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 33,754 shares of company stock valued at $17,691,621. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.